Identification of Pathogenic Bacteria of Diabetes Foot Ulcer
Condition(s) studied
Investigational drug(s) / intervention(s)
The infected wound of the patient's foot ulcer was collected: The infected wound of the patient's foot ulcer was collected
Study summary
The objective of this study is to design and develop a gene chip for detecting pathogenic bacteria in diabetic foot infection wounds. This innovative gene chip technology enables rapid and accurate identification of pathogens at the site of infection by detecting the 16SrDNA sequence of pathogenic bacteria.
Diabetic foot infection is a common serious complication in diabetic patients, often accompanied by complex pathogenic bacteria population, and due to the variety of infection types, traditional pathogen detection methods are time-consuming and low accuracy, patients may miss the best treatment opportunity. Now commonly used genetic identification of pathogenic bacteria often find a variety of bacteria, resulting in the actual pathogenic bacteria difficult to judge.
Eligibility
Primary outcome measure(s)
- Diagnostic accuracy of gene chips:Sensitivity, Specificity, Positive Predictive Value (PPV), NegativePredictive Value (NPV) — through study completion, an average of 1 year
- The time (in minutes) taken for diagnosis using the gene chip method compared to the traditional method. — through study completion, an average of 1 year
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| National Clinical Medical Research Center for Metabolic Diseases (Shanghai) | Shanghai | China |
More Shanghai Jiao Tong University School of Medicine trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06777810 on ClinicalTrials.gov ↗ ← All trials in China